Masayuki Hirokawa
About
In The Last Decade
Masayuki Hirokawa
35 papers receiving 316 citations
Peers
Comparison fields: 5 of 72
- Surgery 212
- Internal Medicine 141
- Dermatology 61
- Pulmonary and Respiratory Medicine 38
- Oncology 38
Countries citing papers authored by Masayuki Hirokawa
This map shows the geographic impact of Masayuki Hirokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Hirokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Hirokawa more than expected).
Fields of papers citing papers by Masayuki Hirokawa
This network shows the impact of papers produced by Masayuki Hirokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Hirokawa. The network helps show where Masayuki Hirokawa may publish in the future.
Co-authorship network of co-authors of Masayuki Hirokawa
This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Hirokawa. A scholar is included among the top collaborators of Masayuki Hirokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Hirokawa. Masayuki Hirokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 16 | |
| 5 | 44 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 0 | |
| 9 | 10 | |
| 10 | 0 | |
| 11 | 16 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 39 | |
| 15 | 3 | |
| 16 | 0 | |
| 17 | 3 | |
| 18 | [Autologous peripheral blood stem cell transplantation for CHOP-resistant mediastinal diffuse large B-cell lymphoma]. | 1 |
| 19 | 4 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.